Systematic toxicological study of PFOS/PFOA co-exposure driving prostate cancer: Core target identification, TME immune remodeling, and combination drug prediction

This study employs an integrative computational framework combining network pharmacology, machine learning, and ODE kinetic modeling to demonstrate that co-exposure to PFOS and PFOA drives prostate cancer progression by disrupting the androgen receptor axis, activating the PI3K-AKT pathway, and remodeling the tumor microenvironment into an immunosuppressive state, while identifying a synergistic drug combination of enzalutamide and Alpelisib as a potential therapeutic intervention.

The Gist

Imagine your body is a bustling city, and the prostate is a specific neighborhood within it. Now, picture two invisible, stubborn pollutants called PFOS and PFOA (types of "forever chemicals" found in everything from non-stick pans to water supplies) as a pair of mischievous saboteurs trying to break into that neighborhood.

This study acts like a high-tech detective agency, using a massive digital toolkit to figure out exactly how these saboteurs cause trouble in the prostate and how we might stop them. Here is what they found, broken down simply:

1. The Detective Work: Finding the Culprits

The researchers didn't just guess; they built a "multi-module analytical framework." Think of this as a super-powered search engine that cross-referenced thousands of data points.

• The Hunt: They looked for the specific "locks" (targets) on the city's buildings that these chemicals could pick.
• The Shortlist: From a huge list of 100 possible suspects, they narrowed it down to just 18 core targets. These are the main doors the chemicals use to get in.
• The Evidence: They used computer simulations (molecular docking) to see how well the chemicals fit into these locks. It was like watching a key slide perfectly into a lock. The chemicals fit very tightly into the Androgen Receptor (AR), AKT1, and PTEN locks.

2. How the Sabotage Happens: The Three-Pronged Attack

Once inside, these chemicals don't just cause random chaos; they follow a specific playbook to turn the neighborhood into a cancer zone:

• Disrupting the Boss: They mess with the Androgen Receptor (AR), which is like the neighborhood's mayor. By tampering with the mayor's office, they confuse the instructions for cell growth.
• Flipping the Switch: They hit the PI3K-AKT pathway, which acts like a gas pedal for cell growth. The chemicals press this pedal down, telling cells to grow faster than they should.
• Breaking the Brakes: They interfere with PTEN, which is supposed to be the emergency brake. When the brakes fail, the car (the cell) speeds out of control.

3. The Neighborhood Becomes a Fortress (The Tumor Microenvironment)

The study also looked at the "neighborhood watch" (the immune system).

• The Result: In the high-risk groups (where the chemicals are active), the neighborhood watch was kicked out. The study found a significant drop in CD8+ T cells (the body's elite soldiers that hunt down bad cells).
• The Analogy: It's like the saboteurs not only took over the buildings but also locked the police station and fired the security guards. This creates an "immunosuppressive" environment where cancer cells can hide and grow without being stopped.

4. The Simulation: Testing a Counter-Attack

Finally, the researchers ran a computer simulation (using math models called ODEs) to see what would happen if they tried to stop this attack.

• The Strategy: They tested a "two-pronged" attack using two drugs: Enzalutamide (which targets the "mayor" or Androgen Receptor) and Alpelisib (which hits the "gas pedal" or PI3K-AKT pathway).
• The Outcome: The simulation showed that using these two drugs together was the most effective strategy, predicting a 33.9% reduction in tumor cell growth. It's like using a master key to lock the front door while simultaneously cutting the power to the gas pedal.

The Bottom Line

This paper claims that PFOS and PFOA drive prostate cancer by teaming up to mess with the cell's growth controls (the gas pedal and brakes) and by firing the body's security guards. The study provides a digital blueprint showing that attacking both the growth signals and the hormonal signals at the same time is the best way to slow down this specific type of cancer progression.

Technical Summary

Technical Summary: Systematic Toxicological Study of PFOS/PFOA Co-exposure Driving Prostate Cancer

Problem Statement
Per- and polyfluoroalkyl substances (PFAS), specifically perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), are persistent environmental pollutants epidemiologically linked to an elevated risk of prostate cancer (PCa). Despite this association, the precise molecular mechanisms by which combined PFOS/PFOA exposure drives prostate cancer progression, and their specific dynamic effects on the tumor microenvironment (TME), remain poorly understood. This study addresses the need to elucidate these mechanisms and identify potential therapeutic interventions through a systematic computational approach.

Methodology
The authors constructed a multi-module analytical framework integrating network pharmacology, computational biology, and machine learning to dissect the toxicological impact of PFOS/PFOA co-exposure:

1. Target Identification: The study employed ADMET toxicity prediction and aggregated targets from multiple databases. A three-way Venn analysis was used to identify shared targets between PFOS/PFOA and prostate cancer. Subsequent screening involved panoramic Gene Ontology (GO) and KEGG enrichment, focused analysis of the androgen receptor (AR) axis, GWAS genetic association validation, and protein-protein interaction (PPI) network construction. Machine learning-based independent screening and a relaxed intersection strategy were applied to refine the target list.
2. Risk Modeling and Pathway Analysis: A "PFAS-PTS score," weighted purely by Cox coefficients, was developed to stratify patients. This score drove Gene Set Variation Analysis (GSVA) for pathway enrichment and TME deconvolution.
3. Kinetic and Interaction Modeling: The study utilized Ordinary Differential Equation (ODE)-based kinetic modeling to simulate tumor-immune dynamics. Molecular docking was performed to assess binding affinities between PFOS/PFOA and key proteins.
4. Therapeutic Prediction: Drug intervention simulations were conducted to predict the efficacy of combination therapies in inhibiting tumor progression.

Key Results

• Core Target Identification: From an initial pool of 100 shared targets, the multi-module screening process identified 18 core targets. These targets were significantly enriched in the androgen receptor (AR) signaling axis, the PI3K-AKT pathway, and cell cycle regulation.
• Molecular Interactions: Molecular docking confirmed strong binding affinities between PFOS/PFOA and critical proteins: AR (-9.49/-8.56 kcal/mol), AKT1 (-7.56/-6.93 kcal/mol), and PTEN (-6.36/-6.08 kcal/mol).
• Pathway Dysregulation: GSVA analysis of the high-risk group (based on the PFAS-PTS score) revealed significant upregulation of the G2M checkpoint and E2F target gene pathways (padj < 0.001), while the androgen response pathway was notably downregulated (padj = 4.8e-4).
• TME Remodeling: Deconvolution of the TME (using dataset GSE141445 and NNLS) indicated that the high-risk group exhibited a significantly increased proportion of tumor cells (p = 2.4e-4) and a marked reduction in CD8+ T cell infiltration (p = 5.7e-4), suggesting the creation of an immunosuppressive microenvironment.
• Kinetic Dynamics: ODE-based modeling confirmed that PFAS exposure promotes tumor cell proliferation and suppresses immune surveillance in a dose-dependent manner.
• Drug Prediction: Simulation of drug interventions identified the combination of enzalutamide and Alpelisib as achieving optimal tumor cell inhibition, with a predicted reduction of 33.9% in the ODE model.

Significance and Claims
The paper claims that PFOS/PFOA promote prostate cancer progression through a multi-target synergistic mechanism involving the disruption of the AR axis, activation of the PI3K-AKT pathway, and dysregulation of the cell cycle, all while reshaping the TME into an immunosuppressive state. The study positions its integrative computational framework as a systematic tool for generating evidence to support risk assessment and the identification of therapeutic interventions for PFAS-associated prostate cancer. The authors emphasize that their work provides a structured computational basis for understanding the complex interplay between environmental pollutants and cancer biology, specifically highlighting the potential of combination drug strategies.